BNP Paribas Financial Markets’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q1
Sell
-395
Closed -$2.31K 3373
2022
Q4
$2.31K Sell
395
-10,667
-96% -$62.3K ﹤0.01% 3064
2022
Q3
$74.1K Buy
11,062
+10,946
+9,436% +$73.3K ﹤0.01% 3171
2022
Q2
$488 Buy
116
+8
+7% +$34 ﹤0.01% 3310
2022
Q1
$364 Sell
108
-24,426
-100% -$82.3K ﹤0.01% 3473
2021
Q4
$77.3K Buy
24,534
+24,426
+22,617% +$76.9K ﹤0.01% 3020
2021
Q3
$353 Buy
108
+11
+11% +$36 ﹤0.01% 3332
2021
Q2
$409 Sell
97
-10,900
-99% -$46K ﹤0.01% 3383
2021
Q1
$54.9K Buy
10,997
+5,259
+92% +$26.2K ﹤0.01% 3024
2020
Q4
$72.5K Sell
5,738
-1,002
-15% -$12.7K ﹤0.01% 2727
2020
Q3
$66.2K Buy
6,740
+5,505
+446% +$54.1K ﹤0.01% 2710
2020
Q2
$12.3K Sell
1,235
-6,881
-85% -$68.5K ﹤0.01% 2987
2020
Q1
$71.7K Buy
8,116
+2,904
+56% +$25.7K ﹤0.01% 2766
2019
Q4
$48.1K Buy
5,212
+1,790
+52% +$16.5K ﹤0.01% 3007
2019
Q3
$20.1K Buy
3,422
+1,049
+44% +$6.17K ﹤0.01% 3305
2019
Q2
$28.5K Sell
2,373
-2,058
-46% -$24.7K ﹤0.01% 3132
2019
Q1
$53.5K Buy
4,431
+4,424
+63,200% +$53.4K ﹤0.01% 2877
2018
Q4
$88 Sell
7
-689
-99% -$8.66K ﹤0.01% 3524
2018
Q3
$10.3K Hold
696
﹤0.01% 3047
2018
Q2
$11.7K Sell
696
-3,065
-81% -$51.6K ﹤0.01% 3064
2018
Q1
$86.1K Buy
3,761
+39
+1% +$893 ﹤0.01% 2693
2017
Q4
$96.3K Buy
3,722
+2,043
+122% +$52.9K ﹤0.01% 2670
2017
Q3
$24.8K Sell
1,679
-131
-7% -$1.93K ﹤0.01% 2984
2017
Q2
$25.3K Buy
1,810
+1,778
+5,556% +$24.8K ﹤0.01% 3011
2017
Q1
$546 Sell
32
-257
-89% -$4.39K ﹤0.01% 3244
2016
Q4
$2.97K Sell
289
-933
-76% -$9.6K ﹤0.01% 3227
2016
Q3
$12.4K Buy
1,222
+578
+90% +$5.84K ﹤0.01% 3111
2016
Q2
$7.23K Buy
644
+570
+770% +$6.4K ﹤0.01% 3077
2016
Q1
$1.01K Sell
74
-2,780
-97% -$38K ﹤0.01% 2507
2015
Q4
$54.1K Sell
2,854
-327
-10% -$6.2K ﹤0.01% 2758
2015
Q3
$59.7K Buy
3,181
+1,901
+149% +$35.7K ﹤0.01% 2728
2015
Q2
$19.1K Buy
+1,280
New +$19.1K ﹤0.01% 3081
2014
Q3
Sell
-69
Closed -$697 3748
2014
Q2
$697 Buy
+69
New +$697 ﹤0.01% 3038